glp 1 starts with r resM Glucagon-like peptide-1 and glucagon-like peptide-1
Description
Schedule a Free Consultation to discuss which GLP-1 medication fits your goals
But that may be because those previous studies included a higher proportion of people who were prescribed GLP-1s for diabetes, while the new study skewed toward people who specifically took the medicines for obesity
Discontinuation rates: Despite higher absolute side effect rates, discontinuation due to adverse events is similar between medications (approximately 5-7% in trials)
and patents pending from Roche Diabetes Care
